• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Apr 22;13:844727.
doi: 10.3389/fimmu.2022.844727. eCollection 2022.
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection


Amélie Guihot[SUP] 1 2 [/SUP], Isabelle Plu[SUP] 3 [/SUP], Cathia Soulié[SUP] 4 [/SUP], Alice Rousseau[SUP] 1 [/SUP], Cecilia Nakid-Cordero[SUP] 1 [/SUP], Karim Dorgham[SUP] 1 [/SUP], Christophe Parizot[SUP] 2 [/SUP], Elena Litvinova[SUP] 2 [/SUP], Julien Mayaux[SUP] 5 [/SUP], Isabelle Malet[SUP] 4 [/SUP], Paul Quentric[SUP] 1 [/SUP], Béhazine Combadière[SUP] 1 [/SUP], Christophe Combadière[SUP] 1 [/SUP], Olivia Bonduelle[SUP] 1 [/SUP], Lucille Adam[SUP] 1 [/SUP], Pierre Rosenbaum[SUP] 1 [/SUP], Alexandra Beurton[SUP] 5 [/SUP], Patrice Hémon[SUP] 6 [/SUP], Patrice Debré[SUP] 1 [/SUP], Vincent Vieillard[SUP] 1 [/SUP], Brigitte Autran[SUP] 1 [/SUP], Danielle Seilhean[SUP] 3 [/SUP], Frédéric Charlotte[SUP] 7 [/SUP], Anne-Geneviève Marcelin[SUP] 4 [/SUP], Guy Gorochov[SUP] 1 2 [/SUP], Charles-Edouard Luyt[SUP] 8 9 [/SUP]



Affiliations

Abstract

The immunopathological pulmonary mechanisms leading to Coronavirus Disease (COVID-19)-related death in adults remain poorly understood. Bronchoalveolar lavage (BAL) and peripheral blood sampling were performed in 74 steroid and non-steroid-treated intensive care unit (ICU) patients (23-75 years; 44 survivors). Peripheral effector SARS-CoV-2-specific T cells were detected in 34/58 cases, mainly directed against the S1 portion of the spike protein. The BAL lymphocytosis consisted of T cells, while the mean CD4/CD8 ratio was 1.80 in non-steroid- treated patients and 1.14 in steroid-treated patients. Moreover, strong BAL SARS-CoV-2 specific T-cell responses were detected in 4/4 surviving and 3/3 non-surviving patients. Serum IFN-γ and IL-6 levels were decreased in steroid-treated patients when compared to non-steroid treated patients. In the lung samples from 3 (1 non-ICU and 2 ICU) additional deceased cases, a lymphocytic memory CD4 T-cell angiopathy colocalizing with SARS-CoV-2 was also observed. Taken together, these data show that disease severity occurs despite strong antiviral CD4 T cell-specific responses migrating to the lung, which could suggest a pathogenic role for perivascular memory CD4 T cells upon fatal COVID-19 pneumonia.

Keywords: Autopsia; Broncho-alveolar lavage (BAL); COVID-19; T cell responses; Vasculitis.
 
Back
Top Bottom